id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_5800
split_0_train_5800
[ { "id": "split_0_train_5800_passage", "type": "progene_text", "text": [ "These heat shock - induced foci colocalize with CREB - binding protein and heat shock factor-1 ." ], "offsets": [ [ 0, 96 ] ] } ]
[ { "id": "split_0_train_8953_entity", "type": "progene_text", "text": [ "CREB - binding protein" ], "offsets": [ [ 48, 70 ] ], "normalized": [] }, { "id": "split_0_train_8954_entity", "type": "progene_text", "text": [ "heat shock factor-1" ], "offsets": [ [ 75, 94 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5801
split_0_train_5801
[ { "id": "split_0_train_5801_passage", "type": "progene_text", "text": [ "In contrast , the distribution of PDZ-RGS3 does not change during heat stress ." ], "offsets": [ [ 0, 79 ] ] } ]
[ { "id": "split_0_train_8955_entity", "type": "progene_text", "text": [ "PDZ-RGS3" ], "offsets": [ [ 34, 42 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5802
split_0_train_5802
[ { "id": "split_0_train_5802_passage", "type": "progene_text", "text": [ "When overexpressed , C2PA induces heat shock response element ( HSE ) - dependent gene transcription , whereas PDZ-RGS3 does not ." ], "offsets": [ [ 0, 130 ] ] } ]
[ { "id": "split_0_train_8956_entity", "type": "progene_text", "text": [ "C2PA" ], "offsets": [ [ 21, 25 ] ], "normalized": [] }, { "id": "split_0_train_8957_entity", "type": "progene_text", "text": [ "PDZ-RGS3" ], "offsets": [ [ 111, 119 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5803
split_0_train_5803
[ { "id": "split_0_train_5803_passage", "type": "progene_text", "text": [ "These data suggest that the function of C2PA is distinct from that of PDZ-RGS3 , and that C2PA may be involved in the heat shock response in testis ." ], "offsets": [ [ 0, 149 ] ] } ]
[ { "id": "split_0_train_8958_entity", "type": "progene_text", "text": [ "C2PA" ], "offsets": [ [ 40, 44 ] ], "normalized": [] }, { "id": "split_0_train_8959_entity", "type": "progene_text", "text": [ "PDZ-RGS3" ], "offsets": [ [ 70, 78 ] ], "normalized": [] }, { "id": "split_0_train_8960_entity", "type": "progene_text", "text": [ "C2PA" ], "offsets": [ [ 90, 94 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5804
split_0_train_5804
[ { "id": "split_0_train_5804_passage", "type": "progene_text", "text": [ "Identification of mitogen - activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray ." ], "offsets": [ [ 0, 140 ] ] } ]
[ { "id": "split_0_train_8961_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase kinase" ], "offsets": [ [ 18, 59 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5805
split_0_train_5805
[ { "id": "split_0_train_5805_passage", "type": "progene_text", "text": [ "BACKGROUND :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_5806
split_0_train_5806
[ { "id": "split_0_train_5806_passage", "type": "progene_text", "text": [ "Components of the mitogen - activated protein kinase ( MAPK ) cascade have been implicated in apoptotic regulation ." ], "offsets": [ [ 0, 116 ] ] } ]
[ { "id": "split_0_train_8962_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase" ], "offsets": [ [ 18, 52 ] ], "normalized": [] }, { "id": "split_0_train_8963_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 55, 59 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5807
split_0_train_5807
[ { "id": "split_0_train_5807_passage", "type": "progene_text", "text": [ "This study used gene expression profiling analysis to identify and implicate mitogen - activated protein kinase kinase ( MEK5 ) - BMK1 ( big mitogen - activated kinase-1 ) / extracellular signal related protein kinase ( ERK5 ) pathway as a novel target involved in chemoresistance ." ], "offsets": [ [ 0, 282 ] ] } ]
[ { "id": "split_0_train_8964_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase kinase" ], "offsets": [ [ 77, 118 ] ], "normalized": [] }, { "id": "split_0_train_8965_entity", "type": "progene_text", "text": [ "MEK5" ], "offsets": [ [ 121, 125 ] ], "normalized": [] }, { "id": "split_0_train_8966_entity", "type": "progene_text", "text": [ "BMK1" ], "offsets": [ [ 130, 134 ] ], "normalized": [] }, { "id": "split_0_train_8967_entity", "type": "progene_text", "text": [ "big mitogen - activated kinase-1" ], "offsets": [ [ 137, 169 ] ], "normalized": [] }, { "id": "split_0_train_8968_entity", "type": "progene_text", "text": [ "extracellular signal related protein kinase" ], "offsets": [ [ 174, 217 ] ], "normalized": [] }, { "id": "split_0_train_8969_entity", "type": "progene_text", "text": [ "ERK5" ], "offsets": [ [ 220, 224 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5808
split_0_train_5808
[ { "id": "split_0_train_5808_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_5809
split_0_train_5809
[ { "id": "split_0_train_5809_passage", "type": "progene_text", "text": [ "Differential gene expression between apoptotically sensitive ( APO+) and apoptotically resistant ( APO-) MCF-7 cell variants was determined by using microarray and confirmed by reverse transcriptase - polymerase chain reaction ( RT - PCR ) ." ], "offsets": [ [ 0, 241 ] ] } ]
[]
[]
[]
[]
split_0_train_5810
split_0_train_5810
[ { "id": "split_0_train_5810_passage", "type": "progene_text", "text": [ "An apoptotic / viability reporter gene assay was used to deter - mine the effects of the transfection of a dominant - negative mutant of BMK1 ( BMK1 / DN ) in conjunction with apoptotic - inducing agents ( etoposide , tumor necrosis factor - alpha [ TNF ] , or TNF - related apoptosis - inducing ligand [ TRAIL ] ) , with or without phorbol ester ( PMA ) ." ], "offsets": [ [ 0, 356 ] ] } ]
[ { "id": "split_0_train_8970_entity", "type": "progene_text", "text": [ "BMK1" ], "offsets": [ [ 137, 141 ] ], "normalized": [] }, { "id": "split_0_train_8971_entity", "type": "progene_text", "text": [ "BMK1" ], "offsets": [ [ 144, 148 ] ], "normalized": [] }, { "id": "split_0_train_8972_entity", "type": "progene_text", "text": [ "tumor necrosis factor - alpha" ], "offsets": [ [ 218, 247 ] ], "normalized": [] }, { "id": "split_0_train_8973_entity", "type": "progene_text", "text": [ "TNF" ], "offsets": [ [ 250, 253 ] ], "normalized": [] }, { "id": "split_0_train_8974_entity", "type": "progene_text", "text": [ "TNF - related apoptosis - inducing ligand" ], "offsets": [ [ 261, 302 ] ], "normalized": [] }, { "id": "split_0_train_8975_entity", "type": "progene_text", "text": [ "TRAIL" ], "offsets": [ [ 305, 310 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5811
split_0_train_5811
[ { "id": "split_0_train_5811_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_5812
split_0_train_5812
[ { "id": "split_0_train_5812_passage", "type": "progene_text", "text": [ "Of the 1186 genes detected through microarray analysis , MEK5 was increased 22 - fold in APO - cells ." ], "offsets": [ [ 0, 102 ] ] } ]
[ { "id": "split_0_train_8976_entity", "type": "progene_text", "text": [ "MEK5" ], "offsets": [ [ 57, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5813
split_0_train_5813
[ { "id": "split_0_train_5813_passage", "type": "progene_text", "text": [ "Overexpression of MEK5 was confirmed by using RT - PCR analysis ." ], "offsets": [ [ 0, 65 ] ] } ]
[ { "id": "split_0_train_8977_entity", "type": "progene_text", "text": [ "MEK5" ], "offsets": [ [ 18, 22 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5814
split_0_train_5814
[ { "id": "split_0_train_5814_passage", "type": "progene_text", "text": [ "Expression of BMK1 / DN alone resulted in a dose - dependent increase in cell death versus control ( P < .05 ) ." ], "offsets": [ [ 0, 112 ] ] } ]
[ { "id": "split_0_train_8978_entity", "type": "progene_text", "text": [ "BMK1" ], "offsets": [ [ 14, 18 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5815
split_0_train_5815
[ { "id": "split_0_train_5815_passage", "type": "progene_text", "text": [ "In addition , BMK1 / DN enhanced the sensitivity of MCF-7 cells to treatment - induced cell death ( P < .05 ) ." ], "offsets": [ [ 0, 111 ] ] } ]
[ { "id": "split_0_train_8979_entity", "type": "progene_text", "text": [ "BMK1" ], "offsets": [ [ 14, 18 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5816
split_0_train_5816
[ { "id": "split_0_train_5816_passage", "type": "progene_text", "text": [ "The ability of PMA to partially suppress TRAIL - and TNF - induced cell death was inhibited by BMK1 / DN ." ], "offsets": [ [ 0, 106 ] ] } ]
[ { "id": "split_0_train_8980_entity", "type": "progene_text", "text": [ "TRAIL" ], "offsets": [ [ 41, 46 ] ], "normalized": [] }, { "id": "split_0_train_8981_entity", "type": "progene_text", "text": [ "TNF" ], "offsets": [ [ 53, 56 ] ], "normalized": [] }, { "id": "split_0_train_8982_entity", "type": "progene_text", "text": [ "BMK1" ], "offsets": [ [ 95, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5817
split_0_train_5817
[ { "id": "split_0_train_5817_passage", "type": "progene_text", "text": [ "However , only TRAIL - induced activity suppression reached statistical significance ( P < .05 ) ." ], "offsets": [ [ 0, 98 ] ] } ]
[ { "id": "split_0_train_8983_entity", "type": "progene_text", "text": [ "TRAIL" ], "offsets": [ [ 15, 20 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5818
split_0_train_5818
[ { "id": "split_0_train_5818_passage", "type": "progene_text", "text": [ "CONCLUSIONS :" ], "offsets": [ [ 0, 13 ] ] } ]
[]
[]
[]
[]
split_0_train_5819
split_0_train_5819
[ { "id": "split_0_train_5819_passage", "type": "progene_text", "text": [ "The overexpression of MEK5 in APO - MCF-7 breast carcinoma cells shows that this MAPK signaling protein represents a potent survival molecule ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_8984_entity", "type": "progene_text", "text": [ "MEK5" ], "offsets": [ [ 22, 26 ] ], "normalized": [] }, { "id": "split_0_train_8985_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 81, 85 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5820
split_0_train_5820
[ { "id": "split_0_train_5820_passage", "type": "progene_text", "text": [ "Molecular inhibition of MEK5 signaling may represent a mechanism for sensitizing cancer cells to chemotherapeutic regimens ." ], "offsets": [ [ 0, 124 ] ] } ]
[ { "id": "split_0_train_8986_entity", "type": "progene_text", "text": [ "MEK5" ], "offsets": [ [ 24, 28 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5821
split_0_train_5821
[ { "id": "split_0_train_5821_passage", "type": "progene_text", "text": [ "IL-12 plays a significant role in the apoptosis of human T cells in the absence of antigenic stimulation ." ], "offsets": [ [ 0, 106 ] ] } ]
[ { "id": "split_0_train_8987_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 0, 5 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5822
split_0_train_5822
[ { "id": "split_0_train_5822_passage", "type": "progene_text", "text": [ "Interleukin-12 ( IL-12 ) is an immunoregulatory cytokine that plays an essential role in cell - mediated immunity ." ], "offsets": [ [ 0, 115 ] ] } ]
[ { "id": "split_0_train_8988_entity", "type": "progene_text", "text": [ "Interleukin-12" ], "offsets": [ [ 0, 14 ] ], "normalized": [] }, { "id": "split_0_train_8989_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 17, 22 ] ], "normalized": [] }, { "id": "split_0_train_8990_entity", "type": "progene_text", "text": [ "cytokine" ], "offsets": [ [ 48, 56 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5823
split_0_train_5823
[ { "id": "split_0_train_5823_passage", "type": "progene_text", "text": [ "It is known to induce T cell apoptosis in in vivo systems such as graft - versus - host disease ( GVHD ) and experimental autoimmune uveitis ( EAU ) ." ], "offsets": [ [ 0, 150 ] ] } ]
[]
[]
[]
[]
split_0_train_5824
split_0_train_5824
[ { "id": "split_0_train_5824_passage", "type": "progene_text", "text": [ "However , the role of IL-12 in T cell apoptosis in the absence of antigenic stimulation has not been clearly defined ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_8991_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 22, 27 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5825
split_0_train_5825
[ { "id": "split_0_train_5825_passage", "type": "progene_text", "text": [ "This study was conducted to investigate whether IL-12 , in the absence of an antigen , is able to induce T cell apoptosis , and also , which signalling pathways utilized by IL-12 are involved in this process ." ], "offsets": [ [ 0, 209 ] ] } ]
[ { "id": "split_0_train_8992_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 48, 53 ] ], "normalized": [] }, { "id": "split_0_train_8993_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 173, 178 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5826
split_0_train_5826
[ { "id": "split_0_train_5826_passage", "type": "progene_text", "text": [ "Our data clearly showed that IL-12 in the absence of an antigen induces apoptosis in T cells ." ], "offsets": [ [ 0, 94 ] ] } ]
[ { "id": "split_0_train_8994_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 29, 34 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5827
split_0_train_5827
[ { "id": "split_0_train_5827_passage", "type": "progene_text", "text": [ "Flow cytometry and ELISA showed FasL up - regulation and increased IFN-gamma synthesis in IL-12 treated T cells , while Fas and TNF-R1 showed little change ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_8995_entity", "type": "progene_text", "text": [ "IFN-gamma" ], "offsets": [ [ 67, 76 ] ], "normalized": [] }, { "id": "split_0_train_8996_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 90, 95 ] ], "normalized": [] }, { "id": "split_0_train_8997_entity", "type": "progene_text", "text": [ "Fas" ], "offsets": [ [ 120, 123 ] ], "normalized": [] }, { "id": "split_0_train_8998_entity", "type": "progene_text", "text": [ "TNF-R1" ], "offsets": [ [ 128, 134 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5828
split_0_train_5828
[ { "id": "split_0_train_5828_passage", "type": "progene_text", "text": [ "Semi - quantitative RT - PCR demonstrated that IL-12 was able to up - regulate TNF-alpha and FasL mRNA expression ." ], "offsets": [ [ 0, 115 ] ] } ]
[ { "id": "split_0_train_8999_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 47, 52 ] ], "normalized": [] }, { "id": "split_0_train_9000_entity", "type": "progene_text", "text": [ "TNF-alpha" ], "offsets": [ [ 79, 88 ] ], "normalized": [] }, { "id": "split_0_train_9001_entity", "type": "progene_text", "text": [ "FasL" ], "offsets": [ [ 93, 97 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5829
split_0_train_5829
[ { "id": "split_0_train_5829_passage", "type": "progene_text", "text": [ "Furthermore , IL-12 induced apoptosis was associated with caspase-3 , caspase-2 , caspase-7 , DNA fragmentation factor 45 ( DFF45 ) and Fas associated death domain ( FADD ) whereas TNF receptor associated death domain ( TRADD ) and receptor interacting protein ( RIP ) were not ." ], "offsets": [ [ 0, 279 ] ] } ]
[ { "id": "split_0_train_9002_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 14, 19 ] ], "normalized": [] }, { "id": "split_0_train_9003_entity", "type": "progene_text", "text": [ "caspase-3" ], "offsets": [ [ 58, 67 ] ], "normalized": [] }, { "id": "split_0_train_9004_entity", "type": "progene_text", "text": [ "caspase-2" ], "offsets": [ [ 70, 79 ] ], "normalized": [] }, { "id": "split_0_train_9005_entity", "type": "progene_text", "text": [ "caspase-7" ], "offsets": [ [ 82, 91 ] ], "normalized": [] }, { "id": "split_0_train_9006_entity", "type": "progene_text", "text": [ "DNA fragmentation factor 45" ], "offsets": [ [ 94, 121 ] ], "normalized": [] }, { "id": "split_0_train_9007_entity", "type": "progene_text", "text": [ "DFF45" ], "offsets": [ [ 124, 129 ] ], "normalized": [] }, { "id": "split_0_train_9008_entity", "type": "progene_text", "text": [ "Fas associated death domain" ], "offsets": [ [ 136, 163 ] ], "normalized": [] }, { "id": "split_0_train_9009_entity", "type": "progene_text", "text": [ "FADD" ], "offsets": [ [ 166, 170 ] ], "normalized": [] }, { "id": "split_0_train_9010_entity", "type": "progene_text", "text": [ "TNF receptor associated death domain" ], "offsets": [ [ 181, 217 ] ], "normalized": [] }, { "id": "split_0_train_9011_entity", "type": "progene_text", "text": [ "TRADD" ], "offsets": [ [ 220, 225 ] ], "normalized": [] }, { "id": "split_0_train_9012_entity", "type": "progene_text", "text": [ "receptor interacting protein" ], "offsets": [ [ 232, 260 ] ], "normalized": [] }, { "id": "split_0_train_9013_entity", "type": "progene_text", "text": [ "RIP" ], "offsets": [ [ 263, 266 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5830
split_0_train_5830
[ { "id": "split_0_train_5830_passage", "type": "progene_text", "text": [ "Inhibition of Janus tyrosine kinase ( JAK ) was able to suppress IL-12 induced T cell apoptosis ." ], "offsets": [ [ 0, 97 ] ] } ]
[ { "id": "split_0_train_9014_entity", "type": "progene_text", "text": [ "Janus tyrosine kinase" ], "offsets": [ [ 14, 35 ] ], "normalized": [] }, { "id": "split_0_train_9015_entity", "type": "progene_text", "text": [ "JAK" ], "offsets": [ [ 38, 41 ] ], "normalized": [] }, { "id": "split_0_train_9016_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 65, 70 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5831
split_0_train_5831
[ { "id": "split_0_train_5831_passage", "type": "progene_text", "text": [ "Anti - FasL antibody was able to block IL-12 induced T cell apoptosis ." ], "offsets": [ [ 0, 71 ] ] } ]
[ { "id": "split_0_train_9017_entity", "type": "progene_text", "text": [ "FasL" ], "offsets": [ [ 7, 11 ] ], "normalized": [] }, { "id": "split_0_train_9018_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 39, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5832
split_0_train_5832
[ { "id": "split_0_train_5832_passage", "type": "progene_text", "text": [ "In conclusion , our findings suggest that IL-12 is able to induce T cell apoptosis in the absence of an antigen ." ], "offsets": [ [ 0, 113 ] ] } ]
[ { "id": "split_0_train_9019_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 42, 47 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5833
split_0_train_5833
[ { "id": "split_0_train_5833_passage", "type": "progene_text", "text": [ "In addition , the present data suggest that this process is FasL mediated and caspase-3 dependent ." ], "offsets": [ [ 0, 99 ] ] } ]
[ { "id": "split_0_train_9020_entity", "type": "progene_text", "text": [ "FasL" ], "offsets": [ [ 60, 64 ] ], "normalized": [] }, { "id": "split_0_train_9021_entity", "type": "progene_text", "text": [ "caspase-3" ], "offsets": [ [ 78, 87 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5834
split_0_train_5834
[ { "id": "split_0_train_5834_passage", "type": "progene_text", "text": [ "Furthermore , JAK was shown to be involved in this process ." ], "offsets": [ [ 0, 60 ] ] } ]
[ { "id": "split_0_train_9022_entity", "type": "progene_text", "text": [ "JAK" ], "offsets": [ [ 14, 17 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5835
split_0_train_5835
[ { "id": "split_0_train_5835_passage", "type": "progene_text", "text": [ "These results may have significant implications in the understanding of IL-12 mediated T cell apoptosis ." ], "offsets": [ [ 0, 105 ] ] } ]
[ { "id": "split_0_train_9023_entity", "type": "progene_text", "text": [ "IL-12" ], "offsets": [ [ 72, 77 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5836
split_0_train_5836
[ { "id": "split_0_train_5836_passage", "type": "progene_text", "text": [ "Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia - inducible factor ." ], "offsets": [ [ 0, 128 ] ] } ]
[ { "id": "split_0_train_9024_entity", "type": "progene_text", "text": [ "prolyl hydroxylase" ], "offsets": [ [ 71, 89 ] ], "normalized": [] }, { "id": "split_0_train_9025_entity", "type": "progene_text", "text": [ "hypoxia - inducible factor" ], "offsets": [ [ 100, 126 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5837
split_0_train_5837
[ { "id": "split_0_train_5837_passage", "type": "progene_text", "text": [ "The product of the von Hippel - Lindau gene , pVHL , targets the alpha subunits of the heterodimeric transcription factor hypoxia - inducible factor ( HIF ) for polyubiquitination in the presence of oxygen ." ], "offsets": [ [ 0, 207 ] ] } ]
[ { "id": "split_0_train_9026_entity", "type": "progene_text", "text": [ "von Hippel - Lindau" ], "offsets": [ [ 19, 38 ] ], "normalized": [] }, { "id": "split_0_train_9027_entity", "type": "progene_text", "text": [ "pVHL" ], "offsets": [ [ 46, 50 ] ], "normalized": [] }, { "id": "split_0_train_9028_entity", "type": "progene_text", "text": [ "hypoxia - inducible factor" ], "offsets": [ [ 122, 148 ] ], "normalized": [] }, { "id": "split_0_train_9029_entity", "type": "progene_text", "text": [ "HIF" ], "offsets": [ [ 151, 154 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5838
split_0_train_5838
[ { "id": "split_0_train_5838_passage", "type": "progene_text", "text": [ "The binding of pVHL to HIF is governed by the enzymatic hydroxylation of conserved prolyl residues within peptidic motifs present in the HIFalpha family members ." ], "offsets": [ [ 0, 162 ] ] } ]
[ { "id": "split_0_train_9030_entity", "type": "progene_text", "text": [ "pVHL" ], "offsets": [ [ 15, 19 ] ], "normalized": [] }, { "id": "split_0_train_9031_entity", "type": "progene_text", "text": [ "HIF" ], "offsets": [ [ 23, 26 ] ], "normalized": [] }, { "id": "split_0_train_9032_entity", "type": "progene_text", "text": [ "HIFalpha family" ], "offsets": [ [ 137, 152 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5839
split_0_train_5839
[ { "id": "split_0_train_5839_passage", "type": "progene_text", "text": [ "By using a biochemical purification strategy , we have identified a human homolog of Caenorhabditis elegans Egl9 as a HIF prolyl hydroxylase ." ], "offsets": [ [ 0, 142 ] ] } ]
[ { "id": "split_0_train_9033_entity", "type": "progene_text", "text": [ "Egl9" ], "offsets": [ [ 108, 112 ] ], "normalized": [] }, { "id": "split_0_train_9034_entity", "type": "progene_text", "text": [ "HIF prolyl hydroxylase" ], "offsets": [ [ 118, 140 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5840
split_0_train_5840
[ { "id": "split_0_train_5840_passage", "type": "progene_text", "text": [ "In addition , we studied the activity of a structurally diverse collection of low molecular weight inhibitors of procollagen prolyl 4-hydroxylase as potential inhibitors of the HIF hydroxylase ." ], "offsets": [ [ 0, 194 ] ] } ]
[ { "id": "split_0_train_9035_entity", "type": "progene_text", "text": [ "procollagen prolyl 4-hydroxylase" ], "offsets": [ [ 113, 145 ] ], "normalized": [] }, { "id": "split_0_train_9036_entity", "type": "progene_text", "text": [ "HIF hydroxylase" ], "offsets": [ [ 177, 192 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5841
split_0_train_5841
[ { "id": "split_0_train_5841_passage", "type": "progene_text", "text": [ "A model compound of this series stabilized HIF in a variety of cells , leading to the increased production of its downstream target , vascular endothelial growth factor ." ], "offsets": [ [ 0, 170 ] ] } ]
[ { "id": "split_0_train_9037_entity", "type": "progene_text", "text": [ "HIF" ], "offsets": [ [ 43, 46 ] ], "normalized": [] }, { "id": "split_0_train_9038_entity", "type": "progene_text", "text": [ "vascular endothelial growth factor" ], "offsets": [ [ 134, 168 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5842
split_0_train_5842
[ { "id": "split_0_train_5842_passage", "type": "progene_text", "text": [ "Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis ." ], "offsets": [ [ 0, 117 ] ] } ]
[]
[]
[]
[]
split_0_train_5843
split_0_train_5843
[ { "id": "split_0_train_5843_passage", "type": "progene_text", "text": [ "Excitotoxicity may play a role in certain disorders of the motor system thought to be caused by environmentally acquired toxins , including lathyrism and domoic acid poisoning ." ], "offsets": [ [ 0, 177 ] ] } ]
[]
[]
[]
[]
split_0_train_5844
split_0_train_5844
[ { "id": "split_0_train_5844_passage", "type": "progene_text", "text": [ "Motor neurons appear to be particularly susceptible to toxicity mediated via alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ( AMPA ) - kainate receptors ." ], "offsets": [ [ 0, 165 ] ] } ]
[ { "id": "split_0_train_9039_entity", "type": "progene_text", "text": [ "( AMPA ) - kainate receptors" ], "offsets": [ [ 135, 163 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5845
split_0_train_5845
[ { "id": "split_0_train_5845_passage", "type": "progene_text", "text": [ "There is a body of evidence implicating glutamatergic toxicity as a contributory factor in the selective neuronal injury occurring in amyotrophic lateral sclerosis ( ALS ) ." ], "offsets": [ [ 0, 173 ] ] } ]
[]
[]
[]
[]
split_0_train_5846
split_0_train_5846
[ { "id": "split_0_train_5846_passage", "type": "progene_text", "text": [ "Interference with glutamate - mediated toxicity is so far the only neuroprotective therapeutic strategy that has shown benefit in terms of slowing disease progression in ALS patients ." ], "offsets": [ [ 0, 184 ] ] } ]
[]
[]
[]
[]
split_0_train_5847
split_0_train_5847
[ { "id": "split_0_train_5847_passage", "type": "progene_text", "text": [ "Biochemical studies have shown decreased glutamate levels in central nervous system ( CNS ) tissue and increased levels in the cerebrospinal fluid ( CSF ) of ALS patients ." ], "offsets": [ [ 0, 172 ] ] } ]
[]
[]
[]
[]
split_0_train_5848
split_0_train_5848
[ { "id": "split_0_train_5848_passage", "type": "progene_text", "text": [ "CSF from ALS patients is toxic to neurons in culture , apparently via a mechanism involving AMPA receptor activation ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_9040_entity", "type": "progene_text", "text": [ "AMPA receptor" ], "offsets": [ [ 92, 105 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5849
split_0_train_5849
[ { "id": "split_0_train_5849_passage", "type": "progene_text", "text": [ "There is evidence for altered expression and function of glial glutamate transporters in ALS , particularly excitatory amino acid transporter 2 ( EAAT2 ) ." ], "offsets": [ [ 0, 155 ] ] } ]
[ { "id": "split_0_train_9041_entity", "type": "progene_text", "text": [ "glutamate transporters" ], "offsets": [ [ 63, 85 ] ], "normalized": [] }, { "id": "split_0_train_9042_entity", "type": "progene_text", "text": [ "excitatory amino acid transporter 2" ], "offsets": [ [ 108, 143 ] ], "normalized": [] }, { "id": "split_0_train_9043_entity", "type": "progene_text", "text": [ "EAAT2" ], "offsets": [ [ 146, 151 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5850
split_0_train_5850
[ { "id": "split_0_train_5850_passage", "type": "progene_text", "text": [ "Abnormal splice variants of EAAT2 have been detected in human CNS ." ], "offsets": [ [ 0, 67 ] ] } ]
[ { "id": "split_0_train_9044_entity", "type": "progene_text", "text": [ "EAAT2" ], "offsets": [ [ 28, 33 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5851
split_0_train_5851
[ { "id": "split_0_train_5851_passage", "type": "progene_text", "text": [ "Mitochondrial dysfunction may contribute to excitotoxicity in ALS ." ], "offsets": [ [ 0, 67 ] ] } ]
[]
[]
[]
[]
split_0_train_5852
split_0_train_5852
[ { "id": "split_0_train_5852_passage", "type": "progene_text", "text": [ "Induction of neuronal nitric oxide synthase and cyclooxygenase 2 in ALS may also lead to significant interactions with regulation of the glutamate transmitter system ." ], "offsets": [ [ 0, 167 ] ] } ]
[ { "id": "split_0_train_9045_entity", "type": "progene_text", "text": [ "neuronal nitric oxide synthase" ], "offsets": [ [ 13, 43 ] ], "normalized": [] }, { "id": "split_0_train_9046_entity", "type": "progene_text", "text": [ "cyclooxygenase 2" ], "offsets": [ [ 48, 64 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5853
split_0_train_5853
[ { "id": "split_0_train_5853_passage", "type": "progene_text", "text": [ "Certain features of motor neurons may predispose them to the neurodegenerative process in ALS , such as the cell size , mitochondrial activity , neurofilament content , and relative lack of certain calcium - binding proteins and molecular chaperones ." ], "offsets": [ [ 0, 251 ] ] } ]
[ { "id": "split_0_train_9047_entity", "type": "progene_text", "text": [ "chaperones" ], "offsets": [ [ 239, 249 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5854
split_0_train_5854
[ { "id": "split_0_train_5854_passage", "type": "progene_text", "text": [ "Motor neurons appear vulnerable to toxicity mediated by calcium - permeable AMPA receptors ." ], "offsets": [ [ 0, 92 ] ] } ]
[ { "id": "split_0_train_9048_entity", "type": "progene_text", "text": [ "AMPA receptors" ], "offsets": [ [ 76, 90 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5855
split_0_train_5855
[ { "id": "split_0_train_5855_passage", "type": "progene_text", "text": [ "The relatively low expression of the glutamate receptor 2 ( GluR2 ) AMPA receptor subunit and the high current density caused by the large number and density of cell surface AMPA receptors are potentially important factors that may predispose to such toxicity ." ], "offsets": [ [ 0, 261 ] ] } ]
[ { "id": "split_0_train_9049_entity", "type": "progene_text", "text": [ "glutamate receptor 2" ], "offsets": [ [ 37, 57 ] ], "normalized": [] }, { "id": "split_0_train_9050_entity", "type": "progene_text", "text": [ "GluR2" ], "offsets": [ [ 60, 65 ] ], "normalized": [] }, { "id": "split_0_train_9051_entity", "type": "progene_text", "text": [ "AMPA receptor" ], "offsets": [ [ 68, 81 ] ], "normalized": [] }, { "id": "split_0_train_9052_entity", "type": "progene_text", "text": [ "AMPA receptors" ], "offsets": [ [ 174, 188 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5856
split_0_train_5856
[ { "id": "split_0_train_5856_passage", "type": "progene_text", "text": [ "[ The role of lipid metabolism in Alzheimer 's disease ]" ], "offsets": [ [ 0, 56 ] ] } ]
[]
[]
[]
[]
split_0_train_5857
split_0_train_5857
[ { "id": "split_0_train_5857_passage", "type": "progene_text", "text": [ "Lipid metabolism in the central nervous system has been focused as an important factor of Alzheimer 's disease , since the apolipoprotein E gene was discovered as a genetic risk for the disease ." ], "offsets": [ [ 0, 195 ] ] } ]
[ { "id": "split_0_train_9053_entity", "type": "progene_text", "text": [ "apolipoprotein E" ], "offsets": [ [ 123, 139 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5858
split_0_train_5858
[ { "id": "split_0_train_5858_passage", "type": "progene_text", "text": [ "Lipid metabolism in the brain , showing relatively closed environment , necessitates lipid reutilization ." ], "offsets": [ [ 0, 106 ] ] } ]
[]
[]
[]
[]
split_0_train_5859
split_0_train_5859
[ { "id": "split_0_train_5859_passage", "type": "progene_text", "text": [ "Cerebrospinal fluid contains only high - density lipoproteins composed of apoE and apoJ secreted from astrocytes and of apoA-I and apoA-II transported via the blood brain barrier ." ], "offsets": [ [ 0, 180 ] ] } ]
[ { "id": "split_0_train_9054_entity", "type": "progene_text", "text": [ "high - density lipoproteins" ], "offsets": [ [ 34, 61 ] ], "normalized": [] }, { "id": "split_0_train_9055_entity", "type": "progene_text", "text": [ "apoE" ], "offsets": [ [ 74, 78 ] ], "normalized": [] }, { "id": "split_0_train_9056_entity", "type": "progene_text", "text": [ "apoJ" ], "offsets": [ [ 83, 87 ] ], "normalized": [] }, { "id": "split_0_train_9057_entity", "type": "progene_text", "text": [ "apoA-I" ], "offsets": [ [ 120, 126 ] ], "normalized": [] }, { "id": "split_0_train_9058_entity", "type": "progene_text", "text": [ "apoA-II" ], "offsets": [ [ 131, 138 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5860
split_0_train_5860
[ { "id": "split_0_train_5860_passage", "type": "progene_text", "text": [ "These apolipoproteins can bind to beta amyloid and possibly relate to its clearance ." ], "offsets": [ [ 0, 85 ] ] } ]
[ { "id": "split_0_train_9059_entity", "type": "progene_text", "text": [ "apolipoproteins" ], "offsets": [ [ 6, 21 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5861
split_0_train_5861
[ { "id": "split_0_train_5861_passage", "type": "progene_text", "text": [ "The aggregation of phosphorylated tau , found in neurofibrillary tangles in Alzheimer 's brain , is also found in the brain with Niemann - Pick disease , suggesting that the impairment of lipid transport in neuronal cells participates in Alzheimer 's disease ." ], "offsets": [ [ 0, 260 ] ] } ]
[ { "id": "split_0_train_9060_entity", "type": "progene_text", "text": [ "tau" ], "offsets": [ [ 34, 37 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5862
split_0_train_5862
[ { "id": "split_0_train_5862_passage", "type": "progene_text", "text": [ "Mitochondrial function , lipid production , and acetylcholine production are closely related , and these alterations could be involved in cholinergic dysfunction in Alzheimer 's disease ." ], "offsets": [ [ 0, 187 ] ] } ]
[]
[]
[]
[]
split_0_train_5863
split_0_train_5863
[ { "id": "split_0_train_5863_passage", "type": "progene_text", "text": [ "The regulation of lipid metabolism in and outside the brain could be a therapeutic and preventive target for Alzheimer 's disease ." ], "offsets": [ [ 0, 131 ] ] } ]
[]
[]
[]
[]
split_0_train_5864
split_0_train_5864
[ { "id": "split_0_train_5864_passage", "type": "progene_text", "text": [ "Killer Ig - like receptor haplotype analysis by gene content : evidence for genomic diversity with a minimum of six basic framework haplotypes , each with multiple subsets ." ], "offsets": [ [ 0, 173 ] ] } ]
[ { "id": "split_0_train_9061_entity", "type": "progene_text", "text": [ "Killer Ig - like receptor" ], "offsets": [ [ 0, 25 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5865
split_0_train_5865
[ { "id": "split_0_train_5865_passage", "type": "progene_text", "text": [ "Killer Ig - like receptor ( KIR ) genes constitute a multigene family whose genomic diversity is achieved through differences in gene content and allelic polymorphism ." ], "offsets": [ [ 0, 168 ] ] } ]
[ { "id": "split_0_train_9062_entity", "type": "progene_text", "text": [ "Killer Ig - like receptor" ], "offsets": [ [ 0, 25 ] ], "normalized": [] }, { "id": "split_0_train_9063_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 28, 31 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5866
split_0_train_5866
[ { "id": "split_0_train_5866_passage", "type": "progene_text", "text": [ "KIR haplotypes containing a single activating KIR gene ( A-haplotypes ) , and KIR haplotypes with multiple activating receptor genes ( B-haplotypes ) have been described ." ], "offsets": [ [ 0, 171 ] ] } ]
[ { "id": "split_0_train_9064_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 0, 3 ] ], "normalized": [] }, { "id": "split_0_train_9065_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 46, 49 ] ], "normalized": [] }, { "id": "split_0_train_9066_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 78, 81 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5867
split_0_train_5867
[ { "id": "split_0_train_5867_passage", "type": "progene_text", "text": [ "We report the evaluation of KIR gene content in extended families , sibling pairs , and an unrelated Caucasian panel through identification of the presence or absence of 14 KIR genes and 2 pseudogenes ." ], "offsets": [ [ 0, 202 ] ] } ]
[ { "id": "split_0_train_9067_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 28, 31 ] ], "normalized": [] }, { "id": "split_0_train_9068_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 173, 176 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5868
split_0_train_5868
[ { "id": "split_0_train_5868_passage", "type": "progene_text", "text": [ "Haplotype definition included subtyping for the expressed and nonexpressed KIR2DL5 variants , for two alleles of pseudogene 3DP1 , and for two alleles of 2DS4 , including a novel 2DS4 allele , KIR1D ." ], "offsets": [ [ 0, 200 ] ] } ]
[ { "id": "split_0_train_9069_entity", "type": "progene_text", "text": [ "KIR2DL5" ], "offsets": [ [ 75, 82 ] ], "normalized": [] }, { "id": "split_0_train_9070_entity", "type": "progene_text", "text": [ "3DP1" ], "offsets": [ [ 124, 128 ] ], "normalized": [] }, { "id": "split_0_train_9071_entity", "type": "progene_text", "text": [ "2DS4" ], "offsets": [ [ 154, 158 ] ], "normalized": [] }, { "id": "split_0_train_9072_entity", "type": "progene_text", "text": [ "2DS4" ], "offsets": [ [ 179, 183 ] ], "normalized": [] }, { "id": "split_0_train_9073_entity", "type": "progene_text", "text": [ "KIR1D" ], "offsets": [ [ 193, 198 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5869
split_0_train_5869
[ { "id": "split_0_train_5869_passage", "type": "progene_text", "text": [ "KIR1D appears functionally homologous to the rhesus monkey KIR1D and likely arose as a consequence of a 22 nucleotide deletion in the coding sequence of 2DS4 , leading to disruption of Ig - domain 2D and a premature termination codon following the first amino acid in the putative transmembrane domain ." ], "offsets": [ [ 0, 303 ] ] } ]
[ { "id": "split_0_train_9074_entity", "type": "progene_text", "text": [ "KIR1D" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_9075_entity", "type": "progene_text", "text": [ "KIR1D" ], "offsets": [ [ 59, 64 ] ], "normalized": [] }, { "id": "split_0_train_9076_entity", "type": "progene_text", "text": [ "2DS4" ], "offsets": [ [ 153, 157 ] ], "normalized": [] }, { "id": "split_0_train_9077_entity", "type": "progene_text", "text": [ "Ig" ], "offsets": [ [ 185, 187 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5870
split_0_train_5870
[ { "id": "split_0_train_5870_passage", "type": "progene_text", "text": [ "Our investigations identified 11 haplotypes within 12 families ." ], "offsets": [ [ 0, 64 ] ] } ]
[]
[]
[]
[]
split_0_train_5871
split_0_train_5871
[ { "id": "split_0_train_5871_passage", "type": "progene_text", "text": [ "From 49 sibling pairs and 17 consanguineous DNA samples , an additional 12 haplotypes were predicted ." ], "offsets": [ [ 0, 102 ] ] } ]
[]
[]
[]
[]
split_0_train_5872
split_0_train_5872
[ { "id": "split_0_train_5872_passage", "type": "progene_text", "text": [ "Our studies support a model for KIR haplotype diversity based on six basic gene compositions ." ], "offsets": [ [ 0, 94 ] ] } ]
[ { "id": "split_0_train_9078_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 32, 35 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5873
split_0_train_5873
[ { "id": "split_0_train_5873_passage", "type": "progene_text", "text": [ "We suggest that the centromeric half of the KIR genomic region is comprised of three major combinations , while the telomeric half can assume a short form with either 2DS4 or KIR1D or a long form with multiple combinations of several stimulatory KIR genes ." ], "offsets": [ [ 0, 257 ] ] } ]
[ { "id": "split_0_train_9079_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 44, 47 ] ], "normalized": [] }, { "id": "split_0_train_9080_entity", "type": "progene_text", "text": [ "2DS4" ], "offsets": [ [ 167, 171 ] ], "normalized": [] }, { "id": "split_0_train_9081_entity", "type": "progene_text", "text": [ "KIR1D" ], "offsets": [ [ 175, 180 ] ], "normalized": [] }, { "id": "split_0_train_9082_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 246, 249 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5874
split_0_train_5874
[ { "id": "split_0_train_5874_passage", "type": "progene_text", "text": [ "Additional rare haplotypes can be identified , and may have arisen by gene duplication , intergenic recombination , or deletions ." ], "offsets": [ [ 0, 130 ] ] } ]
[]
[]
[]
[]
split_0_train_5875
split_0_train_5875
[ { "id": "split_0_train_5875_passage", "type": "progene_text", "text": [ "Identification of a specific molecular repressor of the peroxisome proliferator - activated receptor gamma Coactivator-1 alpha ( PGC-1alpha ) ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_9083_entity", "type": "progene_text", "text": [ "peroxisome proliferator - activated receptor gamma Coactivator-1 alpha" ], "offsets": [ [ 56, 126 ] ], "normalized": [] }, { "id": "split_0_train_9084_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 129, 139 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5876
split_0_train_5876
[ { "id": "split_0_train_5876_passage", "type": "progene_text", "text": [ "The nuclear co - activator PGC-1alpha is a pivotal regulator of numerous pathways controlling both metabolism and overall energy homeostasis ." ], "offsets": [ [ 0, 142 ] ] } ]
[ { "id": "split_0_train_9085_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 27, 37 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5877
split_0_train_5877
[ { "id": "split_0_train_5877_passage", "type": "progene_text", "text": [ "Inappropriate increases in PGC-1alpha activity have been linked to a number of pathological conditions including heart failure and diabetes mellitus ." ], "offsets": [ [ 0, 150 ] ] } ]
[ { "id": "split_0_train_9086_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 27, 37 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5878
split_0_train_5878
[ { "id": "split_0_train_5878_passage", "type": "progene_text", "text": [ "Previous studies ( Puigserver , P. , Adelmant , G. , Wu , Z. , Fan , M. , Xu , J. , O ' Malley , B. , and Spiegelman , B. M. ( 1999 ) Science 286 , 1368 - 1371 ) have demonstrated an inhibitory domain within PGC-1alpha that limits transcriptional activity ." ], "offsets": [ [ 0, 257 ] ] } ]
[ { "id": "split_0_train_9087_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 208, 218 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5879
split_0_train_5879
[ { "id": "split_0_train_5879_passage", "type": "progene_text", "text": [ "Using this inhibitory domain in a yeast two - hybrid screen , we demonstrate that PGC-1alpha directly associates with the orphan nuclear receptor estrogen - related receptor - alpha ( ERR-alpha ) ." ], "offsets": [ [ 0, 197 ] ] } ]
[ { "id": "split_0_train_9088_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 82, 92 ] ], "normalized": [] }, { "id": "split_0_train_9089_entity", "type": "progene_text", "text": [ "estrogen - related receptor - alpha" ], "offsets": [ [ 146, 181 ] ], "normalized": [] }, { "id": "split_0_train_9090_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 184, 193 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5880
split_0_train_5880
[ { "id": "split_0_train_5880_passage", "type": "progene_text", "text": [ "The binding of ERR-alpha to PGC-1alpha requires the C - terminal AF2 domain of ERR-alpha ." ], "offsets": [ [ 0, 90 ] ] } ]
[ { "id": "split_0_train_9091_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 15, 24 ] ], "normalized": [] }, { "id": "split_0_train_9092_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 28, 38 ] ], "normalized": [] }, { "id": "split_0_train_9093_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 79, 88 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5881
split_0_train_5881
[ { "id": "split_0_train_5881_passage", "type": "progene_text", "text": [ "PGC-1alpha and ERR-alpha have a similar pattern of expression in human tissues , with both being present predominantly in organs with high metabolic needs such as skeletal muscle and kidney ." ], "offsets": [ [ 0, 191 ] ] } ]
[ { "id": "split_0_train_9094_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 0, 10 ] ], "normalized": [] }, { "id": "split_0_train_9095_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 15, 24 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5882
split_0_train_5882
[ { "id": "split_0_train_5882_passage", "type": "progene_text", "text": [ "Similarly , we show that in mice physiological stimuli such as fasting coordinately induces PGC-1alpha and ERR-alpha transcription ." ], "offsets": [ [ 0, 132 ] ] } ]
[ { "id": "split_0_train_9096_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 92, 102 ] ], "normalized": [] }, { "id": "split_0_train_9097_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 107, 116 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5883
split_0_train_5883
[ { "id": "split_0_train_5883_passage", "type": "progene_text", "text": [ "We also demonstrate that under normal conditions PGC-1alpha is located within discrete nuclear speckles , whereas the expression of ERR-alpha results in PGC-1alpha redistributing uniformly throughout the nucleoplasm ." ], "offsets": [ [ 0, 217 ] ] } ]
[ { "id": "split_0_train_9098_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 49, 59 ] ], "normalized": [] }, { "id": "split_0_train_9099_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 132, 141 ] ], "normalized": [] }, { "id": "split_0_train_9100_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 153, 163 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5884
split_0_train_5884
[ { "id": "split_0_train_5884_passage", "type": "progene_text", "text": [ "Finally , we show that the expression of ERR-alpha can dramatically and specifically repress PGC-1alpha transcriptional activity ." ], "offsets": [ [ 0, 130 ] ] } ]
[ { "id": "split_0_train_9101_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 41, 50 ] ], "normalized": [] }, { "id": "split_0_train_9102_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 93, 103 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5885
split_0_train_5885
[ { "id": "split_0_train_5885_passage", "type": "progene_text", "text": [ "These results suggest a novel mechanism of transcriptional control wherein ERR-alpha can function as a specific molecular repressor of PGC-1alpha activity ." ], "offsets": [ [ 0, 156 ] ] } ]
[ { "id": "split_0_train_9103_entity", "type": "progene_text", "text": [ "ERR-alpha" ], "offsets": [ [ 75, 84 ] ], "normalized": [] }, { "id": "split_0_train_9104_entity", "type": "progene_text", "text": [ "PGC-1alpha" ], "offsets": [ [ 135, 145 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5886
split_0_train_5886
[ { "id": "split_0_train_5886_passage", "type": "progene_text", "text": [ "In addition , our results suggest that other co - activators might also have specific repressors , thereby identifying another layer of combinatorial complexity in transcriptional regulation ." ], "offsets": [ [ 0, 192 ] ] } ]
[]
[]
[]
[]
split_0_train_5887
split_0_train_5887
[ { "id": "split_0_train_5887_passage", "type": "progene_text", "text": [ "The expression of alpha-dystrobrevin and dystrophin during skeletal muscle regeneration ." ], "offsets": [ [ 0, 89 ] ] } ]
[ { "id": "split_0_train_9105_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 18, 36 ] ], "normalized": [] }, { "id": "split_0_train_9106_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 41, 51 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5888
split_0_train_5888
[ { "id": "split_0_train_5888_passage", "type": "progene_text", "text": [ "The expression of alpha-dystrobrevin and dystrophin in rat tibialis anterior muscles was chronologically evaluated during a cycle of regeneration after myonecrosis induced by the injection of cardiotoxin ." ], "offsets": [ [ 0, 205 ] ] } ]
[ { "id": "split_0_train_9107_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 18, 36 ] ], "normalized": [] }, { "id": "split_0_train_9108_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 41, 51 ] ], "normalized": [] }, { "id": "split_0_train_9109_entity", "type": "progene_text", "text": [ "cardiotoxin" ], "offsets": [ [ 192, 203 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5889
split_0_train_5889
[ { "id": "split_0_train_5889_passage", "type": "progene_text", "text": [ "In immunohistochemical studies , alpha-dystrobrevin and dystrophin were first stained weakly at the sarcolemma of some regenerating muscle fibers on day 5 ." ], "offsets": [ [ 0, 156 ] ] } ]
[ { "id": "split_0_train_9110_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 33, 51 ] ], "normalized": [] }, { "id": "split_0_train_9111_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 56, 66 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5890
split_0_train_5890
[ { "id": "split_0_train_5890_passage", "type": "progene_text", "text": [ "On day 7 , alpha-dystrobrevin was still stained weakly , whereas dystrophin was stained conspicuously ." ], "offsets": [ [ 0, 103 ] ] } ]
[ { "id": "split_0_train_9112_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 11, 29 ] ], "normalized": [] }, { "id": "split_0_train_9113_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 65, 75 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5891
split_0_train_5891
[ { "id": "split_0_train_5891_passage", "type": "progene_text", "text": [ "After day 10 , alpha - dystrobrevin and dystrophin were both stained conspicuously on almost all regenerating muscle fibers ." ], "offsets": [ [ 0, 125 ] ] } ]
[ { "id": "split_0_train_9114_entity", "type": "progene_text", "text": [ "alpha - dystrobrevin" ], "offsets": [ [ 15, 35 ] ], "normalized": [] }, { "id": "split_0_train_9115_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 40, 50 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5892
split_0_train_5892
[ { "id": "split_0_train_5892_passage", "type": "progene_text", "text": [ "In the Western blot analysis , alpha-dystrobrevin and dystrophin were first detected as visible bands on days 5 and 7 , respectively ." ], "offsets": [ [ 0, 134 ] ] } ]
[ { "id": "split_0_train_9116_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 31, 49 ] ], "normalized": [] }, { "id": "split_0_train_9117_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 54, 64 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5893
split_0_train_5893
[ { "id": "split_0_train_5893_passage", "type": "progene_text", "text": [ "The bands of alpha-dystrobrevin and dystrophin both darkened sequentially up to day 10 ." ], "offsets": [ [ 0, 88 ] ] } ]
[ { "id": "split_0_train_9118_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 13, 31 ] ], "normalized": [] }, { "id": "split_0_train_9119_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 36, 46 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5894
split_0_train_5894
[ { "id": "split_0_train_5894_passage", "type": "progene_text", "text": [ "The protein levels based on the densitometrical analysis of the bands on each day were converted to the percentage of the protein level on day 28 , which was taken as 100 % ." ], "offsets": [ [ 0, 174 ] ] } ]
[]
[]
[]
[]
split_0_train_5895
split_0_train_5895
[ { "id": "split_0_train_5895_passage", "type": "progene_text", "text": [ "The sequential line based on these data showed that alpha-dystrobrevin and dystrophin reached 50 % of the protein level on day 28 by 6.6 and 5.3 days , respectively ." ], "offsets": [ [ 0, 166 ] ] } ]
[ { "id": "split_0_train_9120_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 52, 70 ] ], "normalized": [] }, { "id": "split_0_train_9121_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 75, 85 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5896
split_0_train_5896
[ { "id": "split_0_train_5896_passage", "type": "progene_text", "text": [ "These data provide evidence that alpha-dystrobrevin regenerates more slowly than dystrophin in skeletal muscle ." ], "offsets": [ [ 0, 112 ] ] } ]
[ { "id": "split_0_train_9122_entity", "type": "progene_text", "text": [ "alpha-dystrobrevin" ], "offsets": [ [ 33, 51 ] ], "normalized": [] }, { "id": "split_0_train_9123_entity", "type": "progene_text", "text": [ "dystrophin" ], "offsets": [ [ 81, 91 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5897
split_0_train_5897
[ { "id": "split_0_train_5897_passage", "type": "progene_text", "text": [ "Expression of hpttg proto - oncogene in lymphoid neoplasias ." ], "offsets": [ [ 0, 61 ] ] } ]
[ { "id": "split_0_train_9124_entity", "type": "progene_text", "text": [ "hpttg" ], "offsets": [ [ 14, 19 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5898
split_0_train_5898
[ { "id": "split_0_train_5898_passage", "type": "progene_text", "text": [ "Pituitary tumor - transforming gene ( pttg ) is a distinct proto - oncogene which is expressed in certain normal tissues with high proliferation rate and in a variety of tumors ." ], "offsets": [ [ 0, 178 ] ] } ]
[ { "id": "split_0_train_9125_entity", "type": "progene_text", "text": [ "Pituitary tumor - transforming gene" ], "offsets": [ [ 0, 35 ] ], "normalized": [] }, { "id": "split_0_train_9126_entity", "type": "progene_text", "text": [ "pttg" ], "offsets": [ [ 38, 42 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5899
split_0_train_5899
[ { "id": "split_0_train_5899_passage", "type": "progene_text", "text": [ "PTTG is the vertebrate analog of yeast securins Pds1 and Cut2 with a key role in the regulation of sister chromatid separation during mitosis ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_9127_entity", "type": "progene_text", "text": [ "PTTG" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_9128_entity", "type": "progene_text", "text": [ "securins" ], "offsets": [ [ 39, 47 ] ], "normalized": [] }, { "id": "split_0_train_9129_entity", "type": "progene_text", "text": [ "Pds1" ], "offsets": [ [ 48, 52 ] ], "normalized": [] }, { "id": "split_0_train_9130_entity", "type": "progene_text", "text": [ "Cut2" ], "offsets": [ [ 57, 61 ] ], "normalized": [] } ]
[]
[]
[]